On one hand, increasing SMN expression provides neuroprotective benefit to cell culture and transgenic mouse models for ALS; however, some genetic studies suggest that duplication of SMN1 increases the risk of sporadic ALS. The gene discussed is SMN1; the disease is amyotrophic lateral sclerosis.